Inventor · disambiguated record
Cecile Cros
Also filed as: CROS CECILE · CROS CÉCILE
2 granted patents·3 pending applications·0 citations·filing 2020–2023
27Inventor score
Top patents by PatentIndex Score
5 records- 0158US12403153B2Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorderNUVAMID SA·Filed 2021·Granted Sep 2, 2025·0 cites·9 claims
- 0257US12011454B2Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorderNUVAMID SA·Filed 2023·Granted Jun 18, 2024·0 cites·16 claims
- 0347US2024382511A1Nicotinamide mononucleotide derivatives and use thereof for the treatment of heart failure with preserved ejection fractionNUVAMID SA·Filed 2022·Application pending·0 cites
- 0447US2024335466A1Nicotinamide mononucleotide derivatives for use in the treatment of sapho syndromeNUVAMID SA·Filed 2022·Application pending·0 cites
- 0540US2023018920A1Composition modulating botulinum neurotoxin effectFASTOX PHARMA SA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cecile Cros files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →